Volume 14 • Issue 3 • March 2020 ISSN 1814 3601

Figure 1. Incidence rate of measles cases with rash onset 1–29 February 2020, WHO Western Pacific Region

Pacific island countries and areas

DISCLAIMER: The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO Regional Office for the Western Pacific 2020. All rights reserved *Map of Australia is from the Australian Bureau of Statistics

Table 1. Numbers of confirmed and total (confirmed and compatible) measles cases by month of rash onset, September 2019–February 2020, WHO Western Pacific Region

Source: Measles and rubella monthly country reports to the Western Pacific Regional Office by 20 March 2020

No. of confirmed

Total no. of cases

No. of confirmed

Total no. of cases

No. of confirmed

Total no. of cases

No. of confirmed

Total no. of cases

No. of confirmed

Total no. of cases

No. of confirmed

Total no. of cases

Australia1 28 28 46 46 29 29 18 18 21 21 4 4Brunei Darussalam 1 1 0 0 0 0 0 0 0 0 0 0Cambodia 129 129 184 184 92 92 70 70 83 83 0 0China 171 178 140 146 176 185 221 223 148 155 44 48China, Hong Kong SAR 1 1 1 1 3 3 1 1 0 0 0 0China, Macao SAR 0 0 0 0 0 0 0 0 0 0 0 0Japan 33 34 13 16 9 9 7 8 3 3 2 2Lao People's Democratic Republic 20 27 53 53 75 75 188 188 70 73 22 22Malaysia 63 65 81 83 87 94 50 57 59 59 72 73Mongolia 0 0 0 0 0 0 0 0 0 0 0 0New Zealand 663 674 305 310 152 152 51 52 7 7 0 0Papua New Guinea 0 0 0 0 0 0 3 3 1 1 1 1Philippines2 220 1066 124 820 118 639 20 149 383 1412 173 1082Republic of Korea 4 4 5 5 2 2 2 2 3 3 3 3Singapore 5 6 3 3 1 1 1 1 5 5 2 2Viet Nam 39 155 69 182 42 79 3 15 43 66 15 27Pacific island countries and areas 0 0 2 2 3958 3958 2366 2366 46 46 9 9Western Pacific Region 1377 2368 1026 1851 4744 5318 3001 3153 872 1934 347 1273"-" No data1 Reports only confirmed cases

20202019

Country/areaFebSep Oct Nov Dec Jan

Source: Measles and rubella monthly country reports to the Western Pacific Regional Office by 20 March 2020

FijiTonga

Figure 2. Total (confirmed and compatible) measles cases by month of rash onset, WHO Western Pacific Region, 2015–2020 as of 20 March 2020

0

2 000

4 000

6 000

8 000

10 000

12 000

14 000

16 000

18 000Ja

nFe

bM

ar Apr

May Jun Jul

Aug

Sep

Oct

Nov

Dec

Jan

Feb

Mar Apr

May Jun Jul

Aug

Sep

Oct

Nov

Dec

Jan

Feb

Mar Apr

May Jun Jul

Aug

Sep

Oct

Nov

Dec

Jan

Feb

Mar Apr

May Jun Jul

Aug

Sep

Oct

Nov

Dec

Jan

Feb

Mar Apr

May Jun Jul

Aug

Sep

Oct

Nov

Dec

Jan

Feb

2015 2016 2017 2018 2019 2020

Num

ber o

f mea

sles

cas

es

China Malaysia Mongolia Papua New Guinea Philippines Viet Nam Others

Source: Measles and rubella monthly country reports to WHO by 20 March 2020

Table 2. Status of verification of measles elimination, WHO Western Pacific Region

Source: Measles and rubella monthly country reports to the Western Pacific Regional Office by 20 March 2020

Imported Import-related Endemic

Unknown/ not

reportedImported Import-

related EndemicUnknown

/ not reported

Australia 2014 285 106 149 0 30 89.5% 25 12 10 0 3 88.0%Brunei Darussalam 2015 1 0 0 0 1 0.0% 0 - - - - -Cambodia 2015 676 0 0 0 679 0.0% 83 0 0 0 83 0.0%China - 2 990 0 0 0 2 990 0.0% 182 0 0 0 182 0.0%China, Hong Kong SAR 2016 90 39 42 0 9 90.0% 0 - - - - -China, Macao SAR 2014 35 18 17 0 0 100.0% 0 - - - - -Japan 2015 737 116 500 0 121 83.6% 5 2 1 0 2 60.0%Lao People's Democratic Republic - 1 037 0 0 0 785 0.0% 92 0 0 0 92 0.0%Malaysia - 993 5 0 791 197 80.2% 131 1 0 118 12 90.8%Mongolia - 2 0 0 0 2 0.0% 0 - - - - -New Zealand 2017 2 173 28 469 0 1 680 22.9% 7 1 3 0 3 57.1%Papua New Guinea - 3 0 0 0 3 0.0% 2 0 0 0 2 0.0%Philippines1 - 6 604 248 13 4 880 1 463 77.8% 556 35 0 431 90 83.8%Republic of Korea 2014 190 86 101 0 3 98.4% 6 6 0 0 0 100.0%Singapore 2018 152 33 2 0 117 23.0% 7 2 0 0 5 28.6%Viet Nam - 3 169 0 0 0 2 995 0.0% 62 0 0 0 62 0.0%Pacific island countries and areas - 6 346 0 0 0 6 346 0.0% 55 0 0 0 55 0.0%Total 25 483 679 1 293 5 671 17 421 30.0% 1 213 59 14 549 591 51.3%

Blue No measles casesGreen ≥80%Yellow 60–79%Red <60%

Source of infection % of cases with known

source of infection

Country/area Year verified

2020

No. of confirmed

cases

Source of infection % of cases with known

source of infection

2019

No. of confirmed

cases

2

3

Table 3. Measles case classification and incidence by country and area, WHO Western Pacific Region, 2016—2020 as of 20 March 2020

Clinically compatible Lab Epi-

linked

Total confirmed

and clinically

compatible1

Annualized measles

incidence per 1 million pop.

Australia 99 4.1 81 3.3 101 4.1 285 11.4 25.4 NA3 0 0 0 25 0 25 5.9 0 26-Feb-20

Brunei Darussalam 1 2.4 0 0.0 1 2.3 1 2.3 0.4 2 0 2 0 0 0 0 0.0 0 13-Sep-19

Cambodia 56 3.6 10 0.6 3 0.2 676 41.0 16.7 352 2 267 0 83 0 83 29.8 1 31-Jan-20

China 24 839 17.7 5 993 4.3 3 975 2.8 3 098 2.2 1424.5 2 930 241 2 486 21 182 0 203 0.9 0 29-Feb-20

China, Hong Kong SAR 9 1.2 4 0.5 16 2.2 90 12.0 7.5 0 - - - - - - - 0 1-Dec-19

China, Macao SAR 0 0.0 2 3.2 3 4.7 35 54.5 0.7 3 0 3 0 0 0 0 0.0 0 6-May-19

Japan 163 1.3 188 1.5 279 2.2 761 6.0 126.5 105 17 83 0 5 0 5 0.2 0 26-Feb-20

Lao People's Democratic Republic 8 1.2 3 0.4 10 1.4 1 119 158.4 7.2 200 50 55 3 24 68 95 79.6 0 19-Feb-20

Malaysia 1 587 50.9 1 693 53.5 1 958 61.1 1 036 31.9 32.9 1 776 395 1 249 1 131 0 132 24.1 0 25-Feb-20

Mongolia 28 813 9517.4 9 2.9 1 0.3 2 0.6 3.2 23 0 23 0 0 0 0 0.0 0 4-Mar-19

New Zealand 104 22.3 15 3.2 33 6.9 2 229 465.1 4.8 143 3 133 0 6 1 7 8.7 0 29-Jan-20

Papua New Guinea 0 0.0 7 0.8 15 1.8 3 0.3 8.8 97 1 93 0 2 0 2 1.4 0 6-Feb-20

Philippines 641 6.2 2 432 23.2 22 862 214.6 47 868 442.8 109.7 2 972 0 476 1 940 441 115 2 496 136.5 5 25-Feb-20

Republic of Korea 18 0.4 7 0.1 19 0.4 191 3.7 51.5 110 0 103 0 6 0 6 0.7 0 10-Feb-20

Singapore 157 27.9 81 14.2 37 6.4 162 27.6 5.9 14 0 7 0 7 0 7 7.1 0 1-Feb-20

Viet Nam 368 3.9 592 6.2 1 249 12.9 4 684 48.1 98.4 885 728 34 43 61 1 105 6.4 0 3-Mar-20

Pacific island countries and areas4 6 1.8 2 0.6 0 0.0 6 346 1889.5 3.4 132 7 70 0 4 0 55 97.2 0 13-Jan-20

Fiji 5 5.6 1 1.1 0 0.0 31 33.7 0.9 81 7 70 0 4 0 4 25.9 0 18-Feb-20

New Caledonia - - 1 3.6 0 0.0 0 0.0 0.3 0 - - - - - - - - 10-Jan-17

Samoa - - - - - - 5 707 28691.5 0.2 0 - - - - - - - - 13-Jan-20

Solomon Islands 1 1.7 0 0.0 0 0.0 - - 0.6 0 - - - - - - - - 21-Jan-16

Tonga - - - - - - 608 5525.2 0.1 51 0 0 - - - 51 2755.8 0 13-Feb-20

Vanuatu 0 0.0 - - - - - - 0.3 0 - - - - - - - - 23-Sep-15

Western Pacific Region 56 869 30.1 11 119 5.8 30 562 16.0 62 271 32.4 1927.5 9 744 1 444 5 084 2 008 977 185 3 170 1.6 61 Includes clinically compatible, laboratory confirmed and epi-linked confirmed cases Green <1 confirmed measles case / 1 000 000 population2 United Nations, Department of Economic and Social Affairs, Population Division World Population Prospects 2017 revision. Yellow 1–9.9 confirmed measles case / 1 000 000 population3 Australia reports confirmed cases only. Red >= 10 confirmed cases / 1 000 000 population4 Classification is provisional based on laboratory data only.

2019

Total confirmed

and clinically compatible1

Measles incidence

per 1 million

pop.

Total confirmed and

clinically compatible1

Measles incidence

per 1 million

pop.

Total confirmed and

clinically compatible1

Measles incidence

per 1 million

pop.

2016

Total confirmed and

clinically compatible1

Measles incidence

per 1 million

pop.

20182017

Country/area

2020

Rash onset of last

confirmed measles

case

Population (in

millions) 2

Suspected measles

cases

Pending classification

Discarded cases3

Measles cases

Deaths due to

measles

3

4

Table 4. Measles surveillance performance indicators by country and area, WHO Western Pacific Region, 2019—2020 as of 20 March 2020

Discarded non-measles rate per

100 000 pop

Annualized discarded non-measles rate per 100

000 pop

≥ 2 ≥ 2

Australia 3 Insufficient data Insufficient data Insufficient data Insufficient data Insufficient data Insufficient data Insufficient data Insufficient data

Brunei Darussalam 4.6 Not applicable 100.0% 95.2% 2.7 Not applicable 100.0% 100.0%

Cambodia 9.2 96.0% 91.3% 96.4% 9.6 80.0% 88.9% 97.7%

China 5.3 77.4% 96.8% 79.7% 1.0 0.0% 94.3% 69.6%

China, Hong Kong SAR 0.1 Not applicable 100.0% 90.8% - Not applicable - -

China, Macao SAR 14.8 Not applicable 97.7% 97.7% 2.8 Not applicable 100.0% 100.0%

Japan 2.1 23.4% Insufficient data Insufficient data 0.4 0.0% Insufficient data Insufficient data

Lao People's Democratic Republic 13.0 100.0% 85.2% 85.6% 4.6 44.4% 59.1% 96.2%

Malaysia 26.9 93.8% 86.7% 93.7% 22.8 93.8% 84.2% 96.7%

Mongolia 10.6 50.0% 94.4% 95.2% 4.3 22.7% 100.0% 100.0%

New Zealand 2.0 Insufficient data Insufficient data Insufficient data 16.5 Insufficient data Insufficient data Insufficient data

Papua New Guinea 1.0 15.0% 76.6% 87.2% 6.4 40.0% 80.4% 85.6%

Philippines 1.7 27.8% 30.0% 39.1% 2.6 11.1% 43.8% 49.1%

Republic of Korea 8.7 100.0% 87.2% 97.2% 1.2 5.9% 90.0% 98.2%

Singapore 1.8 Not applicable 73.7% 73.7% 0.7 Not applicable 100.0% 92.9%

Viet Nam 0.8 14.3% 30.7% 43.3% 0.2 1.6% 8.9% 59.2%

Pacific island countries and areas4 13.4 10.0% Insufficient data Insufficient data 12.4 5.0% Insufficient data Insufficient data

Western Pacific Region 48.8 46.8% 67.7% 63.8% 45.4 20.5% 64.9% 67.4%Green Reached or surpassed target

Yellow Nearly reached target: 1.00–1.99 for non-measles suspected case rate; 10.1–25% for percent clinically confirmed cases; 60–79% for other indicators

Red Substantially below target

2020

Second level units with≥ 2 discarded cases per

100 000 pop [annualized]1

Suspected cases with adequate investigation

Suspected cases with adequate specimens for laboratory confirmation 2

≥ 80% ≥ 80% ≥ 80%≥ 80% ≥ 80%

Country/area

2019

Second level units with≥ 2 discarded cases per

100 000 pop [annualized]1

Suspected cases with adequate investigation

Suspected cases with adequate specimens for laboratory confirmation 2

≥ 80%

1 This indicator is not applicable for countries which have no second-level administrative units2 Adequate specimen defined as blood specimen collected within 28 days of rash onset or other specimen (throat swab, nasopharyngeal swab, cerebrospinal fluid, urine) collected within 5 days of rash onset; excludes epidemiologically-linked cases.3 Reports only confirmed cases4 Surveillance performance indicators refer to all the Pacific island countries and areas as one epidemiological block; each country is considered as second level unit

5

Table 5. Rubella case classification and incidence by country and area, WHO Western Pacific Region, 2016–2020 as of 20 March 2020

Clinically compatible

casesLab Epi-linked

Australia - - - - - - - - 25.40 - - - - - - - - -

Brunei Darussalam 0 0.0 0 0.0 0 0.0 0 0.0 0.44 2 0 2 0 0 0 0 0.0 -

Cambodia 4 0.3 7 0.4 3 0.2 30 1.8 16.72 352 4 339 0 9 0 9 3.2 -

China 4 476 3.2 1 601 1.1 3 935 2.8 32 568 22.9 1 424.55 2 930 241 1 450 286 797 156 1 239 5.2 -

China, Hong Kong SAR 3 0.4 1 0.1 11 1.5 48 6.4 7.55 1 0 0 0 1 0 1 0.8 -

China, Macao SAR 1 1.6 0 0.0 1 1.6 78 121.5 0.65 3 0 0 0 3 0 3 27.6 -

Japan3 3 0.0 5 0.0 68 0.5 2 394 18.9 126.50 147 10 79 4 54 0 58 2.8 -

Lao People's Democratic Republic 40 5.9 12 1.7 15 2.2 11 1.6 7.16 200 0 147 0 3 0 3 2.5 -

Malaysia 68 2.2 113 3.6 175 5.5 154 4.7 32.87 1 788 395 1 379 0 14 0 14 2.6 -

Mongolia 27 8.9 13 4.2 1 0.3 2 0.6 3.21 23 0 23 0 0 0 0 0.0 -

New Zealand - - - - - - 1 0.2 4.83 0 - - - - - - - -

Papua New Guinea 2 0.2 1 0.1 1 0.1 5 0.6 8.76 97 1 95 0 0 0 0 0.0 -

Philippines 165 1.6 448 4.3 152 1.4 182 1.7 109.70 2 972 0 2 778 0 186 8 194 10.6 -

Republic of Korea 3 0.1 2 0.0 0 0.00 8 0.2 51.51 12 0 11 0 1 0 1 0.1 -

Singapore 0 0.0 3 0.5 16 2.8 7 1.2 5.94 4 0 2 1 1 0 2 2.0 -

Viet Nam 350 3.7 126 1.3 102 1.1 69 0.7 98.36 80 34 36 9 1 0 10 0.6 -

Pacific island countries and areas2 1 0.3 4 1.2 0 0.0 0 0.0 3.40 81 7 74 0 0 0 0 0.0 -

Fiji 1 1.1 4 4.4 0 0.0 0 0.0 0.92 81 7 74 0 0 0 0 0.0 -

New Caledonia 0 0.0 0 0.0 0 0.0 0 0.0 0.29 0 - - - - - - - -

Solomon Islands - - 0 0.0 - - - - 0.65 0 - - - - - - - -

Vanuatu 0 0.0 - - - - - - 0.29 0 - - - - - - - -

Western Pacific Region 5 143 2.7 2 336 1.2 4 480 2.3 35 557 18.5 1927.54 8 692 692 6 415 300 1 070 164 1 534 4.8 -1 United Nations, Department of Economic and Social Affairs, Population Division World Population Prospects 2017 revision Green <1 confirmed measles case / 1 000 000 population

2 Classification is provisional based on laboratory data only. Yellow 1–9.9 confirmed measles case / 1 000 000 population

3 Rubella cases are cases reported as suspected measles cases that were identified as rubella laboratory confirmed cases during the investigation. This represents a small proportion of a large number of rubella cases occurring in Japan during 2018 Red >= 10 confirmed cases / 1 000 000 population

"-" No data Gray No data

2017

Annualized Rubella

incidence per 1 million pop.

Congenital rubella

syndrome

2018 2019

Investigated for rubella

Pending classification

Discarded cases

Rubella casesTotal

confirmed and clinically compatible

Total confirmed

and clinically compatible

Rubella incidence per 1 million pop.

Rubella incidence per 1 million pop.

Total confirmed

and clinically compatible

Rubella incidence per 1 million pop.

2020

Population (in millions) 1

Rubella incidence per 1 million pop.

2016

Total confirmed

and clinically compatible

Country/areaTotal

confirmed and clinically compatible

6

Table 6A. Measles and rubella laboratory testing, WHO Western Pacific Region, 2019

No. No. % No. %No.

receivedNo. (+)

No. of samples tested

No. of isolates

No. of samples tested

No. (+) No. No. % No. %

Australia VIDRL 225 225 195 14 12 85.7 0 0% 0 - 92.9 57 17 209 199 192 1 1 100% 0 0%

Brunei Darussalam DLS 24 22 22 22 2 9.1 1 5% 0 - 95.8 1 1 1 0 2 22 0 0% 0 0%

Cambodia NIPH 2 195 2 195 2 195 2 116 674 31.9 2 0% 79 1 83.6 0 - 0 - 675 2 191 30 1% 0 0%

China CCDC - - - - - - - - - - 95.8 - - - - - - - - - -

China, Hong Kong SAR PHLC 2 893 2 893 1 787 1 394 59 4.2 12 1% 0 - 98.8 87 36 1 425 108 110 414 43 10% 7 2%

China, Macao SAR PHL 829 829 507 506 31 6.1 9 2% 0 - 100.0 0 - 383 52 62 505 39 8% 17 3%

Japan NIID 10 633 10 481 6 164 677 206 30.4 86 13% 0 - No data 0 - 3 018 652 737 1 604 1 171 73% 66 4%

Lao People's Democratic Republic NCLE 1 013 1 013 1 013 1 008 152 15.1 18 2% 0 - 89.2 0 - 0 - 152 1 013 14 1% 25 2%

Malaysia NPHL 18 638 18 638 12 059 11 542 1 212 10.5 231 2% 0 - 92.0 5 048 22 0 - 1 120 9 790 375 4% 171 2%

Mongolia NCCD 338 338 338 338 2 0.6 0 0% 0 - 100.0 0 - 0 - 2 337 3 1% 0 0%

New Zealand CHL 3 723 3 723 3 535 239 94 39.3 6 3% 0 - 91.5 18 0 3 487 2 095 2 062 23 2 9% 1 4%

Papua New Guinea CPHL 55 55 55 55 1 1.8 1 2% 0 - 62.5 0 - 0 - 1 55 5 9% 1 2%

Philippines RITM 29 333 8 250 8 215 8 219 4 817 58.6 281 3% 31 7 48.2 0 - 2 757 1 939 6 463 3 164 245 8% 94 3%

Republic of Korea KCDC 8 091 8 091 4 969 3 276 186 5.7 91 3% 0 - 56.7 0 - 4 350 281 375 359 57 16% 29 8%

Singapore NPHL 870 870 841 86 20 23.3 3 3% 0 - 95.3 129 49 798 138 207 86 1 1% 2 2%

Viet Nam national lab (Northern) NIHE 1 216 1 216 1 187 974 740 76.0 5 1% 0 - 99.6 183 4 241 192 916 295 9 3% 0 0%

Viet Nam national lab (Southern) PI 4 324 4 324 4 320 4 309 1 864 43.3 14 0% 0 - 53.6 15 0 15 0 1 864 3 509 29 1% 16 0%

Viet Nam subnational lab (Central) PI 1 375 1 375 1 375 1 375 1 242 90.3 9 1% 0 - 53.7 5 0 15 10 1 242 860 0 0% 1 0%

Viet Nam subnational lab (Highland) IHE 1 541 1 541 1 541 1 542 1 396 90.5 11 1% 0 - 50.4 0 - 0 - 1 395 1 028 1 0% 1 0%

Fiji FCCDC 483 472 472 444 28 6.3 14 3% 0 - No data 0 - 9 4 28 201 6 3% 0 0%

Total 87 799 66 551 50 790 38 136 12 738 33. 4 794 2% 110 8 72.2 5 543 129 16 708 5 670 17 605 25 457 2 031 8% 431 2%

"-" No data

Country/area Laboratory

Measles and rubellaMeasles Rubella

Serology Virus detection

Total number of

lab confirmed

cases

Serum and blood (includes DBS)Serum Blood

% of samples

with results ≤4

days

Measles Virus isolation/ detection

(swab, urine and others)

Measles Reverse

Transcription- Polymerase Chain

Reaction

Total number

of samples received

Total number

of samples tested

Total number of cases tested

Samples tested for

measles IgMMeasles IgM (+)

Measles IgM equiv

DBS samples Samples

tested for rubella IgM

Rubella IgM (+)Rubella

IgM equiv

7

Table 6B. Measles and rubella laboratory testing, WHO Western Pacific Region, 2020 as of 20 March 2020

No. No. % No. %No.

receivedNo. (+)

No. of samples tested

No. of isolates

No. of samples tested

No. (+) No. No. % No. %

Australia VIDRL 20 20 19 0 - - - - - - 3 0 20 19 19 0 - - - -

Brunei Darussalam DLS 2 2 2 2 0 0% 0 0% 0 - 95.8 0 - 0 - 0 2 0 0% 0 0%

Cambodia NIPH 825 825 825 825 280 34% 0 0% 24 1 98.7 0 - 0 - 280 822 13 2% 0 0%

China CCDC - - - - - - - - - 95.8 - - - - - - - - - -

China, Hong Kong SAR PHLC 90 90 68 57 1 2% 0 0% - 94.6 0 - 30 0 1 27 1 4% 0 0%

China, Macao SAR PHL 24 24 15 15 3 20% 1 7% - 100.0 0 - 10 0 3 15 1 7% 0 0%

Japan NIID 348 341 200 15 3 20% 4 27% - - 0 - 86 3 5 50 31 62% 7 14%

Lao People's Democratic Republic NCLE 105 105 105 105 25 24% 7 7% - 90.5 0 - 0 - 25 105 3 3% 3 3%

Malaysia NPHL 3 460 3 460 2 166 2 024 224 11% 57 3% - 86.6 561 0 0 - 224 1 848 84 5% 43 2%

Mongolia NCCD 18 18 18 18 0 0% 0 0% - 100.0 0 - 0 - 0 18 0 0% 0 0%

New Zealand CHL 62 62 61 2 1 50% 0 0% - 50.0 0 - 60 7 7 1 0 - 0 -

Papua New Guinea CPHL 81 81 81 81 4 5% 0 0% - 66.7 0 - 0 - 4 81 1 1% 2 2%

Philippines RITM 1 835 1 674 1 621 1 624 725 45% 38 2% 4 1 94.7 0 - 132 51 766 898 270 30% 22 2%

Republic of Korea KCDC 262 262 164 129 8 6% 3 2% - 30.4 0 - 129 7 10 30 3 10% 2 7%

Singapore NPHL 84 84 81 5 2 40% 1 20% - 100.0 7 1 52 5 8 5 0 0% 0 0%

Viet Nam national lab (Northern) NIHE 96 96 96 96 67 - 1 - - - 0 - 0 - 67 28 2 - 0 -

Viet Nam national lab (Southern) PI 280 280 280 279 246 88% 3 1% 0 - - 0 - 0 - 246 54 6 11% 0 0%

Viet Nam subnational lab (Central) PI 439 439 439 439 369 - 3 - - - 0 - 0 - 369 75 0 - 0 0%

Viet Nam subnational lab (Highland) IHE 1 1 1 1 1 100% 0 0% - - 0 - 0 - 1 0 - - - -

Fiji FCCDC 84 83 83 83 4 5% 6 7% 0 - - 0 - 0 - 4 11 0 0% 0 0%

Total 8 116 7 947 6 325 5 800 1 963 34% 124 2% 28 2 91.1 571 1 519 92 2 039 4 070 415 10% 79 2%

"-" No data

Country/area Laboratory

Measles and rubellaMeasles Rubella

Serology Virus detection

Total number of

lab confirmed

cases

Serum and blood (includes DBS)Serum Blood

% of samples

with results ≤4

days

Measles Virus isolation/ detection

(swab, urine and others)

Measles Reverse

Transcription- Polymerase Chain

Reaction

Total number

of samples received

Total number

of samples tested

Total number of cases tested

Samples tested for

measles IgMMeasles IgM (+)

Measles IgM equiv

DBS samples Samples

tested for rubella IgM

Rubella IgM (+)Rubella

IgM equiv

8

Figure 3. Measles genotype distribution of cases with rash onset in 2019 and 2020, WHO Western Pacific Region

Table 7. Measles genotype distribution of cases with rash onset in March 2019 to February 2020, WHO Western Pacific Region

2019 2020

B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1Australia 4 32 5 20 4 11 1 23 1 8 5 2 8 3 7 1 2 3 12 4Brunei Darussalam 1Cambodia 9 8 6 3 3 2 3 4China 3 10 1 53 10 11 37 9 8 18 1 15 15 1 11 14 10 1 3 10 2China, Hong Kong SAR 30 1 51 5 2 6 1 6 2 1 1 1 2 1China, Macao SAR 10 1 15 1 2 1Japan 23 30 43 23 53 30 11 23 2 11 8 2 1 3 1 2 1Lao People's Democratic Republic 7Malaysia 6 3 1 1 1 9 1 8MongoliaNew Zealand 11 1 20 1 11 7 4 11 20 31 16 42 14 47 1 36 11 18 6 3 2 1Papua New GuineaPhilippines 3 6 45Republic of Korea 4 44 2 7 1 6 5 6 11 2 3 2 1Singapore 9 4 5 2 3 4 9 40 7 7 2 2 3 1 2 2 2Viet Nam 27 21 19 13 19 5 1Pacific island countries and areas 3

AugMay JulJun Sep Oct Nov Dec2019

Jan2020

FebAprMarCountry/area

Source: Measles and rubella monthly country reports to the Western Pacific Regional Office by 20 March 2020

The boundaries and names shown and the designations used on the maps do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO Regional Office for the Western Pacific 2020. All rights reserved.

9

Figure 4. Rubella genotype distribution of cases with rash onset in 2019 and 2020, WHO Western Pacific Region

Table 8. Rubella genotype distribution of cases with rash onset in March 2019 to February 2020, WHO Western Pacific Region

2019 2020

Source: Measles and rubella monthly country reports to the Western Pacific Regional Office by 20 March 2020

2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J

Australia

Brunei Darussalam

Cambodia 1China 172 279 294 460 223 422 195 200 40 52 16 19 10 19 24 13 2 13 1China, Hong Kong SAR 3 8 10 1 5 4 1 2 1 1 1China, Macao SAR 31 20Japan 2 116 12 84 17 80 7 80 2 58 25 1 12 7 1 3 4 2 6 2 3Lao People's Democratic Republic

Malaysia

Mongolia

New Zealand 1Papua New Guinea

Philippines

Republic of Korea 1 1 1 1 1Singapore 1 1Viet Nam

Pacific island countries and areas

2019

OctMay Jun Jul Aug Sep FebNov DecMar AprCountry/area Jan

2020

The boundaries and names shown and the designations used on the maps do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO Regional Office for the Western Pacific 2020. All rights reserved.

Table 9A. Completeness and timeliness of epidemiologic reporting, WHO Western Pacific Region, 2019—2020

Table 9B. Completeness and timeliness of laboratory reporting, WHO Western Pacific Region, 2019—2020

Vaccine-Preventable Diseases and Immunization Regional Office for the Western Pacific

World Health Organization

P.O. Box 2932, 1000 Manila, PhilippinesTel. No. (63 2) 85288001

Fax No. (63 2) 85211036, 85260279Please send your comments and monthly data before the 10th of the month to: WPROEPIdata@who.int

More detailed information available in theRegional and country profile of measles elimination

Jan Feb

Australia 100% 92% 10 Feb 17 Mar 100% 50%

Brunei Darussalam 100% 100% 06 Feb 02 Mar 100% 100%

Cambodia 100% 100% 10 Feb 10 Mar 100% 100%

China 100% 33% 15 Feb 17 Mar 100% 100%

China, Hong Kong SAR 92% 92% 07 Feb 06 Mar 100% 100%

China, Macao SAR 100% 100% 10 Feb 09 Mar 100% 100%

Japan 100% 67% 11 Feb 23 Mar 100% 0%

Lao People's Democratic Republic 100% 100% 10 Feb 10 Mar 100% 100%

Malaysia 100% 83% 10 Feb 09 Mar 100% 100%

Mongolia 100% 100% 10 Feb 10 Mar 100% 100%

New Zealand 100% 100% 10 Feb 10 Mar 100% 100%

Papua New Guinea 75% 25% 10 Feb 10 Mar 100% 100%

Philippines 67% 17% 19 Feb 13 Mar 100% 50%

Republic of Korea 92% 33% 10 Feb 10 Mar 100% 100%

Singapore 100% 100% 10 Feb 09 Mar 100% 100%

Viet Nam 92% 92% 10 Feb 10 Mar 100% 100%

Pacific island countries and areas 100% 92% 14 Feb 13 Mar 100% 100%

Completeness 95% 100% 100% 100%

Timeliness 78% 88% 82% 88%1 National measles surveillance monthly reports from February 2020. Legend: black = timely report; red = untimely report

3 Countries and areas should submit reports by the 10th (or the next working day) of the following month; Pacific island countries and areas and China may report to the Regional Office by the 15th (or the next working day) of the following month.

2020 1

2 Completeness is defined as the number of reports received by the end of the reporting month divided by the number of expected reports for the year.

Completeness 2 Timeliness 3Country

2019

Completeness 2 Timeliness 3

Australia 100% 92% 07 Feb 06 Mar 100% 100%

Brunei Darussalam 100% 100% 07 Feb 02 Mar 100% 100%

Cambodia 100% 108% 10 Feb 10 Mar 100% 100%

China 100% 100% 06 Feb 02 Mar 100% 100%

China, Hong Kong SAR 100% 100% 07 Feb 06 Mar 100% 100%

China, Macao SAR 100% 100% 10 Feb 10 Mar 100% 100%

Japan 100% 58% 11 Feb 23 Mar 100% 0%

Lao People's Democratic Republic 100% 100% 10 Feb 10 Mar 100% 100%

Malaysia 100% 83% 12 Feb 11 Mar 100% 0%

Mongolia 100% 100% 10 Feb 10 Mar 100% 100%

New Zealand 100% 100% 10 Feb 10 Mar 100% 100%

Papua New Guinea 75% 67% 06 Feb 10 Mar 100% 100%

Philippines 92% 83% 10 Feb 10 Mar 100% 100%

Republic of Korea 100% 100% 10 Feb 10 Mar 100% 100%

Singapore 100% 100% 09 Feb 09 Mar 100% 100%

Viet Nam national lab (Northern) 100% 92% 10 Feb 10 Mar 100% 100%

Viet Nam national lab (Southern) 100% 100% 10 Feb 10 Mar 100% 100%

Viet Nam subnational lab (Central) 100% 92% 10 Feb 10 Mar 100% 100%

Viet Nam subnational lab (Highland) 100% 92% 10 Feb 10 Mar 100% 100%

Fiji 100% 92% 15 Feb 13 Mar 100% 100%

Completeness 98% 100% 100% 100%

Timeliness 92% 85% 90% 90%1 National measles laboratory monthly reports from February 2020.

2 Completeness is defined as the number of reports received by the end of the reporting month divided by the number of expected reports for the year.

3 National measles and rubella laboratories should submit monthly reports by the 10th (or the next working day) of the following month.

2020 1

Country/area

2019

Completeness 2 Timeliness 3 Jan Feb Completeness 2 Timeliness 3